These findings suggest that the increase in IFN‐γ expression in the CR group and its decrease in treatment groups indicate that FO and F can help prevent or reduce inflammation, potentially slowing down or preventing pathological processes in kidney diseases. The gene discussed is IFNG; the disease is kidney disorder.